Napieralski, Rudolf <br/><br/>
Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2005 
 - 3025-31 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-1605  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Nuclear--genetics<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cell Cycle Proteins--genetics<br/>Cisplatin--administration & dosage<br/>DNA-Binding Proteins--genetics<br/>Dihydrouracil Dehydrogenase (NADP)--genetics<br/>Endonucleases--genetics<br/>Female<br/>Fluorouracil--administration & dosage<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Ku Autoantigen<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Nuclear Proteins--genetics<br/>Predictive Value of Tests<br/>Prognosis<br/>RNA, Messenger--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction--methods<br/>Stomach Neoplasms--drug therapy<br/>Survival Analysis<br/>Thymidine Phosphorylase--genetics<br/>Thymidylate Synthase--genetics<br/>Treatment Outcome